# Andros Pharmaceuticals Co.,Ltd (6917.TWO): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Andros Pharmaceuticals Co.,Ltd (6917.TWO) is 28/100, ranked against 24,000+ stocks in 35 markets (Quality 33, Value 23, Momentum 59, each scored against its sector).

- StockRank: 28/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 33, Value 23, Momentum 59: each a 0-100 percentile within the stock's sector.
- Position: #19,454 overall, #1,682 in Healthcare.
- Listing: Taiwan, TWO; Healthcare / Biotechnology.
- Last close: 33.95 TWD on 13 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/6917.TWO
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker